EGFR+ NSCLC in 2021: Key highlights of the year

Learning objective:         

After watching this broadcast, participants should be able to:

• Describe key data on the diagnosis and management of patients with EGFR-positive NSCLC from 2021
• Contextualise key learnings from 2021 into clinical practice through case study discussion and evaluation

Scientific Committee:

• Matthew Krebs (UK)
• Antonio Passaro (Italy)

Faculty:

• Zosia Piotrowska (USA)
• Keith Kerr (UK)
• Solange Peters (Switzerland)

Claim your CPD credits

The content of the following has been certified by the CPD Certification Service as conforming to continuing professional development principles.

You can claim 1 credit for this activity.

Please make a note of the below information to claim your points.

Name of activity: Janssen Oncology Medical Education (OME) webinar five: EGFR+ NSCLC in 2021: Key highlights of the year

Certificate number: A029778

Date of activity: January 2022

Provider: Sciterion 013096